Revance Therapeutics | 销售毛利



Gross Profit On Sales 更改 日
AbbVie USD 10.71B 458M 2024-12
ALKERMES USD 257.31M 110.81M 2025-03
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
J&J USD 14.6B 816M 2025-03
Merck USD 12.77B 849M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
P&G USD 10.1B 1.37B 2025-03
Pacira USD 134.62M 12.75M 2025-03
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12



Revance Therapeutics 销售毛利 - 当前值，历史数据，预测，统计，图表和经济日历 - Jul 2025.